Top section
Top section
◆ The threat of US corporate issuance to European borrowers ◆ The new funding environment for Middle East banks ◆ Reviving UK equity capital markets
Swiss investors retain appetite for credit as yields become more attractive
As war drags on, banks are boosting hoards of cash after deposit outflows
Data
More articles
More articles
More articles
-
Drug developer SK Biopharmaceuticals priced its IPO high last Friday, netting W959.3bn ($792m), according to a source close to the deal. -
Kangji Medical Holdings has bagged HK$3.59bn ($464.2m) after pricing its Hong Kong listing at the top of the marketed range.
-
In this round-up, the Chinese capital of Beijing conducts nucleic acid tests for Covid-19 on 2.3m local residents, the central bank leaves the benchmark lending rate unchanged for June, and a subsidiary of AIA is set to become China’s first wholly foreign owned life insurance company.
-
Far East Horizon, a Hong Kong-listed financial services firm, has launched a $1bn loan into general syndication.
-
US investment managers GMO and Greylock will again unite to begin negotiations with Belize after the government said on Wednesday it wanted to delay all bond payments until February.
-
Peru's largest commercial lender Banco de Crédito del Perú (BCP) will begin fixed income investor calls on Monday as it contemplates a tier two capital bond issue, just two weeks after parent company Credicorp issued a debut $500m senior deal.
Sub-sections
-
Sponsored by CAF – Development Bank of Latin America and the Caribbean
CAF gearing up to transform regional development
-
Sponsored by Emirates NBD Capital
Emirates NBD Capital: An unrivalled conduit for Middle East liquidity
-
-
Sponsored by European Investment Bank
European Investment Bank: Supporting sustainable development in North Africa
